Coronavirus vaccines will save 2021? “Light at the end of the tunnel”
DOI:
https://doi.org/10.46900/apn.v3i1(January-April).81Keywords:
COVID-19, Pandemic, VaccineAbstract
On 11 March, the WHO confirmed coronavirus disease 2019 as a pandemic. The Director-General of the WHO called on governments to change its course by taking "urgent and aggressive action" (1). In terms of the number of deaths COVID-19 has caused 1.919.126 deaths, reported to WHO as of January 10, 2021. (https://covid19.who.int).
The COVID-19 pandemic has posed unprecedent challenges to healthcare worldwide, including neurosurgical units. Medical workers, pediatric neurosurgeons included, should be aware of safety measures and follow the recommendations of local healthcare organizations to prevent and control the disease (2).
During the year 2020 the scientific community worked tirelessly in search of a solution to stop the COVID-19. Several scientific studies have been published analyzing the effects of different drugs on the stages of COVID-19. However, in an unprecedented way in history independent groups have produced different options for vaccines against coronavirus (3).
The vaccination rollout comes with a mixed bag of emotions and hope. We cannot celebrate yet, but it is certainly a relief to start the year 2021 with the hope of COVID-19 control. A terrible disease that has been
producing lethal effects and sequelae in different peoples around the world.
COVID-19 has exposed vulnerabilities, magnified weaknesses, and exacerbated long-festering issues. We will continue to believe in science and overcome this terrible obstacle in our lives.
It’s the light at the end of the tunnel. We’re not there yet, but it’s a big relief to know there can be an end to this pandemic.
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Ricardo Santos de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
When publishing in Archives of Pediatric Neurosurgery journal, authors retain the copyright of their article and agree to license their work using a Creative Commons Attribution 4.0 International Public License (CC BY 4.0), thereby accepting the terms and conditions of this license (https://creativecommons.org/licenses/by/4.0/legalcode).
The CC BY 4.0 license terms applies to both readers and the publisher and allows them to: share (copy and redistribute in any medium or format) and adapt (remix, transform, and build upon) the article for any purpose, even commercially, provided that appropriate credit is given to the authors and the journal in which the article was published.
Authors grant Archives of Pediatric Neurosurgery the right to first publish the article and identify itself as the original publisher. Under the terms of the CC BY 4.0 license, authors allow the journal to distribute the article in third party databases, as long as its original authors and citation details are identified.
